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Probing intermolecular backbone H-bonding in serine 
proteinase-protein inhibitor complexes 
Wuyuan Lu , l* Michael Randal*, Anthony Kossiakoff** and Stephen BH Kent1 
Background: Intermolecular backbone H-bonding (N-H...O=C) is a common 
occurrence at the interface of protein-protein complexes. For instance, the 
amide NH groups of most residues in the binding loop of eglin c, a potent 
serine proteinase inhibitor from the leech Hirudo medicina/is, are H-bonded to 
the carbonyl groups of residues in the target enzyme molecules such as 
chymotrypsin, elastase and subtilisins. We sought to understand the energetic 
significance of these highly conserved backbone-backbone H-bonds in the 
enzyme-inhibitor complexes. 
Results: We synthesized an array of backbone-engineered ester analogs of 
eglin c using native chemical ligation to yield five inhibitor proteins each 
containing a single backbone ester bond from P3 to P2’ (i.e. -CONH- to 
-COO-). The structure at the ligation site (P6-P5) is essentially unaltered as 
shown by a high-resolution analysis of the subtilisin-BPN’-eglin c complex. The 
free-energy changes (MGNH*O) associated with the binding of ester analogs 
at P3, Pl and P2’ with bovine a-chymotrypsin, subtilisin Carlsberg and porcine 
pancreatic elastase range from O-4.5 kcallmol. Most markedly, the NH+0 
substitution at P2 not only stabilizes the inhibitor but also enhances binding to 
the enzymes by as much as 500-fold. 
Conclusions: Backbone H-bond contributions are context dependent in the 
enzyme-eglin c complexes. The interplay of rigidity and adaptability of the binding 
loop of eglin c seems to play a prominent role in defining the binding action. 
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Introduction 
The energetic significance of H-bonding in protein 
folding, stability and recognition remains a debated issue 
in protein chemistry [l-4]. Despite significant progress in 
the past decade, our understanding of the energetic para- 
meters of H-bonding is still limited because of our very 
limited ability to engineer H-bonds to systematically eval- 
uate the individual effects such as electrostatics, entropy 
and solvation [5-61. 
An especially important class of H-bonds in proteins 
involve backbone-backbone interactions between the 
amide NH group (donor) and the carbonyl C=O group 
(acceptor) [7-91. Backbone-backbone H-bonding is 
thought to be critically important in stabilizing a helices 
and !3 sheets in a folded protein [7]. Furthermore, back- 
bone H-bonds are commonly encountered at the inter- 
face of many protein complexes, suggesting they have a 
prominent role in protein recognition [S]. By their 
nature, backbone H-bonds are less affected by entropic 
factors than their sidechain counterparts. Consequently, 
studying this major group of H-bonds will focus our 
understanding on the solvation and electrostatic proper- 
ties of H-bonding. Studies on backbone-backbone 
H-bonding have so far been severely hindered, however, 
by the lack of the experimental means to directly probe 
its role. 
Chemical synthesis [lo-l 11 and in vitro protein translation 
[12] are probably the only two viable techniques available 
for protein backbone engineering. Recently, the Schultz 
laboratory [13] used unnatural amino acid mutagenesis to 
replace three backbone peptide bonds with an ester bond 
in an a helix of T4 lysozyme. It was found that the loss of 
terminal H-bonds in the a helix destabilized the protein 
by -0.8 kcal/mol, whereas breakage of the H-bond in the 
middle destabilized the protein by 1.7 kcal/mol. 
Previously we reported the total synthesis, via native 
chemical ligation [14], of a backbone-engineered analog 
of turkey ovomucoid third domain (OMTKY3, a protein 
inhibitor of serine proteinases), in which the amide 
peptide bond between Thr17 and Leul8 was replaced 
by an ester bond, that is, -CONH- to -COO- [15]. This 
chemical mutation eliminated a highly conserved back- 
bone H-bond donated by the NH group of LeulS to the 
carbonyl C=O groups in the enzyme. Consequently, the 
binding energy of the inhibitor to six different serine 
proteinases decreased by an average of 1.5 kcal/mol, 
which was attributed to the loss of the intermolecular 
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backbone-backbone H-bond in the enzyme-inhibitor Eglin c of the leech Hirtcdo me&huh is a potent protein 
complex. Recently, the ester-containing OMTKY3 com- inhibitor of many serine proteinases in both the trypsin and 
plexed with Streptomyces griseus proteinase B has been subtilisin families of enzymes. Crystal structures of eglin c 
crystallized, and the resultant structure did not show any complexed with bovine a-chymotrypsin (CHYM) [16] and 
appreciable difference, both locally and globally, to the three different subtilisins [17-201 have shown that eglin c, 
structure of wild-type OMTKY3 complexed with the like many other standard-mechanism protein proteinase 
same enzyme (K.S. Bateman and M.N.G James, personal inhibitors [Zl], adopts a canonical binding-loop conforma- 
communication). To further our understanding of the tion upon complexation with its cognate enzymes [Z]. At 
biophysical roles of H-bonding, we have used the native the interface of the eglin c complexes, there exist a 
chemical ligation technique to extend protein backbone number of backbone H-bonds, which have also been 
engineering and the synthesis of an array of ester-substi- observed in most other serine proteinase-protein inhibitor 
tuting backbone analogs of the protein eglin c, and complexes. The energetic significance of these H-bonds to 
examined the effect on binding to serine proteinases. binding and catalysis has not been determined, however. 
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Table 1 
Association equilibrium constants for recombinant eglin c and 
synthetic (8-7O)S41C eglin c at pH 7.0 with three serine 
proteinases. 
K, CM-‘) 
Enzyme Recombinant 
CHYM 1.9x10” 
SCAR 9.1 x10” 
PPE 6.7 x 1 O7 
Synthetic 
2.0x10” 
6.8x 10” 
6.9x107 
To investigate the energetic contributions of intermolecu- 
lar H-bonding in these enzyme-protein inhibitor com- 
plexes, we have used the native chemical ligation 
technique to prepare five backbone-engineered analogs of 
eglin c, in which the amide peptide bond from P3 to P2’ 
[23] was replaced, each in turn, by an ester bond via the 
incorporation of ‘leucic acid’ (i.e. -CONH- 3 -COO-). 
As a control, all corresponding reference compounds with 
‘leucine’ substitution were also synthesized, including 
‘wild-type’ eglin c. In this paper we report on syntheses 
and thermodynamic studies of these synthetic proteins 
interacting with three different serine proteinases: CHYM 
and porcine pancreatic elastase (PPE) of the trypsin family 
and subtilisin Carlsberg (SCAR) of the subtilisin family. In 
addition, the crystal structure of the chemically synthe- 
sized ‘wild-type’ eglin c in complex with subtilisin BPN’ 
(SBPN) at 2.0 A resolution will also be discussed. 
Results and discussion 
Synthesis of ‘wild-type’ (8-7O)S41 C eglin c 
Naturally occurring eglin c consists of 70 amino acid 
residues with no cysteines. X-ray crystallographic studies 
of eglin c complexed with CHYM and subtilisins showed 
that the first seven residues at the amino terminus of the 
inhibitor were not visible in the electron-density map 
[17-191. It was reported that truncation at the amino ter- 
minus of eglin c by six residues [24] and by seven 
residues [ZS] gave rise to a functionally identical 
Figure 2 
inhibitor to the full-length eglin c. For these reasons, we 
chose to synthesize eglin c with the first seven residues 
deleted. In addition, our ‘wild-type’ eglin c construct 
contained a Ser+Cys mutation at position 41 (PS). This 
mutation is necessary to introduce a ligation site, 
-Gly40-Cys41- (Figure 1). As the sidechain of the natural 
PS residue (serine) makes no direct contact with the 
enzyme as was judged by the known crystal structures, 
(8-7O)S41C eglin c was expected to be functionally iden- 
tical to full-length eglin c. To support this, our synthetic 
‘wild-type’ (8-7O)S41C eglin c was carefully compared 
with full-length recombinant eglin c with regard to the 
binding to three different serine proteinases, CHYM, 
SCAR and PPE. As shown in Table 1, association equi- 
librium constants (K,) for synthetic (8-7O)S41C and for 
recombinant eglin c are identical within experimental 
error, indicating that the two different forms of eglin c 
are functionally indistinguishable. 
Backbone geometry at Cys41 
Figure 2 shows the electron density from a ZF,-F,, omit 
map in the region of Cys41 where residues 4042 were left 
out of the phasing model. The map clearly shows that this 
region is well defined. It also shows density extending off 
the Sr of Cys41, suggesting that the cysteine had been oxi- 
dized. Because there was no indication from the mass 
spectrometry analysis that the cysteine had undergone 
oxidation, this probably occurred during crystallization or 
was X-ray induced during data collection. 
Residues 40-42 from this analysis and the 1SBN structure 
are superimposed in Figure 3. The root mean square 
deviation (rmsd) of the mainchain atoms (N, C, and C) 
for these residues is 0.15 A, which indicates that the 
stereochemistry of these residues is identical within the 
error limits of the data. There is a small change in the 
puckering of Pro42, but it does not alter the conformation 
of the mainchain. These data show that native chemical 
ligation characterized by the introduction of a cysteine 
does not affect the conformation of the protein in any 
appreciable way. 
Electron-density map in the region of Cys41 
of synthetic (8-7O)S41 C eglin c complexed 
with SBPN. 
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Figure 3 Table 2 
Superposition of residues 40-42: Gly-Cys-Pro (orange) from synthetic 
eglin c and Gly-Ser-Pro (green) from native sequences (PDB code 
1 sbn, see [191). The rmsd of the mainchain atoms (N, C,, C) for these 
residues is 0.15 A. 
Effects of NH+0 substitutions 
Several factors may contribute to the apparent free- 
energy change AAGamidr+-srer associated with the 
NH-+0 substitution. 
[E>C=O...H,O]+[I>N-H...H,O]= 
[E>C=O...H-N<I]+ZH,O AG, (1) 
[E>C=O...H,O]+[I>O...H,O]= 
[E>C=O O<I]+ZH,O AG, (2) 
In equations (1) and (2) (E, enzyme; I, inhibitor), AG, and 
AG, are the apparent free-energy changes associated with 
the binding to the enzyme of reference analog and ester- 
containing analog, respectively. MGamide+esrer can be 
therefore defined as: 
AAG amide+ester = RT]n(K,am’d”/K,2Sfer) = AGO _ G, = 
AGo...0 + (AGamidesolvation - AGesters,l,,,i,,) - AGHmbond (3) 
As illustrated in the equations, MGamide-+ester can poten- 
tially be affected by: loss of the backbone H-bond, AGH- 
bond; the differential dehydration energy of inhibitors in 
the free form, AGamide so,vation - AGestersolVacion; and the elec- 
trostatic and van der Waals interaction between the two 
oxygen atoms in the H-bond-depleted complex, AGO”‘O. 
We have suggested that although it is difficult to dissect 
(AGO”‘O + AGamidesolvation - AGesrersolvation), its overall contri- 
bution to MGamide+ester is insignificant [15]. In other 
words, the experimentally measured MGamide+ester value 
is more or less a reflection of the energetic consequence of 
loss of a backbone H-bond. Listed in Table 2 are K, values 
and MGamide+ester values for four pairs of eglin c analogs 
interacting with CHYM, SCAR and PPE at pH 7.0. 
Association equilibrium constants for synthetic eglin c analogs 
interacting with three serine proteinases measured at pH 7.0. 
P3 
V43L (K,; M-I) 
V43(O)L (K,; M-‘) 
K, ratio 
MG (kcallmol) 
P2 
T44L (K,; M-l) 
T44(O)L (K,; M-1) 
K, ratio 
MG (kcal/mol) 
Pl 
Wild type (K,; M-I) 
L45(O)L (K,; M-‘) 
K, ratio 
AAG (kcallmol) 
P2’ 
Wild type (K,; M-l) 
L47(O)L (K,; M-l) 
K, ratio 
MG (kcal/mol) 
CHYM 
8.0 x 109 
1.0x109 
10 
1.2 
3.5x107 
1.7xlO’O 
0.002 
-3.6 
2.0x10” 
3.8x108 
500 
3.7 
2.0x10” 
6.8x109 
30 
2.0 
SCAR 
1.7x109 
2.1 x109 
1 
0 
2.9x107 
1.ox1os 
0.3 
-0.7 
6.8~10” 
2.8~10~ 
2500 
4.5 
6.8x10” 
3.2~10’0 
20 
1.8 
PPE 
9.0x107 
5.9x105 
150 
2.9 
1.6~10~ 
3.4x106 
0.5 
-0.4 
6.9x107 
1.9x106 
40 
2.1 
6.9x107 
5.8~10~ 
10 
1.4 
It should be pointed out that one factor that can potentially 
complicate the energetic assessment of MGamide+ester is 
protein destabilization associated with the amide+ester 
substitution. Incorporation of an ester bond into the back- 
bone of a polypeptide is generally expected to destabilize 
the protein owing to increased conformational entropy in 
the denatured state (extra rotational freedom). Although 
destabilization of the denatured state itself may not be 
relevant to the binding of the native protein, compro- 
mised rigidity of the binding loop in the native form 
could significantly affect the outcome. For instance, as 
the binding loop of the inhibitor tends to rigidify upon 
complexation with the enzyme [26], elevated flexibility 
in the same region may weaken the binding to the 
enzyme as a result of an extra entropy loss. On the other 
hand, added flexibility in the backbone may lead to a 
lower energy barrier for conformational adjustment upon 
complexation, therefore resulting in a better adaptation in 
subsite interactions in the enzyme-inhibitor complex, 
and consequently a tighter binding. 
Thermal denaturation studies indicate that the NH+0 
substitutions at positions Pl, P3 and P2’ destabilized these 
three backbone-engineered ester analogs uniformly by 
-6°C with respect to their reference analogs, which is a 
marginal decrease in protein stability, whereas the 
amide+ester substitution at the PZ position enhanced the 
stability of the protein by 7°C (Figure 4). 
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Figure 4 
Melting temperatures determined by Nano- 
DSC at pH 5.4 for four pairs of eglin c 
analogs at positions P3, P2, Pl and P2’. W Control analogs 
W Ester analogs 
P3 P2 Pl Pl’ P2’ 
The Pl position 
The amide NH group of the Pl residue (Leu45 in eglin c) 
H-bonds to the carbonyl C=O group of Ser214 and 
Ser1950r in chymotrypsin (Ser125 and Ser221 in subtil- 
isins, respectively; Figure 5). This H-bonding pattern has 
been observed in most inhibitor-enzyme complexes 
studied [Z&26]. In eglin c, the Pl NH+0 substitution 
weakened the binding to CHYM and SCAR by 500- and 
2400-fold, that is, 3.7 and 4.5 kcal/mol, respectively. 
These results were surprising in light of our previous work 
with OMTKY3, in which the same Pl NH+0 substitu- 
tion caused a decrease in binding to either enzyme by only 
tenfold (1.3 kcal/mol) [ 151. 
It has recently been reported that eglin c and OMTKY3, The amide NH group of the P2 threonine in eglin c is 
with superimposable binding loop conformations in com- H-bonded to GlylOOO in SCAR. This H-bond is absent in 
plexes, are two well-behaved interframe-additive inhibitors the complex with CHYM (Figure 5). It was therefore 
with respect to CHYM and SCAR [27]. In OMTKY3 and anticipated that the P2 NH+0 substitution would 
Figure 5 
Position Chemtstry &Biology 
most other small-protein proteinase inhibitors, however, 
the binding loop is mainly stabilized by flanking disulfide 
bridges between the loop and the scaffold of the inhibitor. 
In the case of eglin c, electrostatic/H-bonding interactions 
are found to be the only forces that support the binding 
loop. Not surprisingly, although the Leu+leucic acid 
replacement at the Pl position did not destabilize 
OMTKY3 [15], it did destabilize eglin c by 6°C at pH 5.4. 
It is not clear why large effects have been observed at PI 
for CHYM and SCAR, but not for PPE, where the 
decrease in binding to PPE upon the Pl NH+0 substitu- 
tion is only 40-fold, or 2.1 kcal/mol. 
The P2 position 
Close-up view of the intermolecular 
backbone H-bonding at the interface of 
(a) CHYM-eglin c [16] and 
(b) SBPN-(8-70)S41 C eglin c. The residues 
of eglin c (P3 to P2’, in Schechter and 
Berger notation) and of the enzyme are 
depicted in gold and green, respectively. The 
mainchain N atoms are blue (cyan for the 
sidechain N atom) and the carbonyl 0 atoms 
are red (pink for the sidechain 0 atom). Only 
the atoms involved in H-bonding are 
displayed in ball-rendering mode. 
1 
1 (a) (W Glyl 00 
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Figure 6 
Thr44 Asp46 I 
Intramolecular H-bonding networks supporting the binding loop as 
seen in synthetic (8-7O)S41 C eglin c complexed with SBPN. 
weaken the binding to SCAR, but not to CHYM. Surpris- 
ingly, although the NH-0 substitution improved the 
binding to SCAR by a factor of 3, it enhanced the binding 
to CHYM by 500-fold. Furthermore, the amide-to-ester 
replacement at the PZ position unexpectedly stabilized 
eglin c by as much as 7°C at pH 5.4. 
The fact that the P2 ester analog (S-70)T44[O]L is more 
stable than (%70)T44L suggests that the ester bond 
incorporation may have resulted in an enthalpically more 
stable native conformer, enough to compensate for the 
entropical destabilization in the denatured state. Appar- 
ently, a significant local conformational adjustment in the 
binding loop had to occur upon ester incorporation. It is 
plausible that the observed enhancement in binding 
resulted from a better binding adaptation in the complex 
as a consequence of the conformational adjustment in the 
binding loop of the inhibitor. A definitive answer requires 
structural determination of both the free inhibitor and 
inhibitor-enzyme complex. 
Notably, a much smaller gain in binding observed for 
SCAR (-0.7 kcal/mol) can at least partially be attributed to 
the loss of the H-bond between Thr44N and GlylOOO, 
which is not present in the complex with chymotrypsin. 
Nonetheless, it is not apparent why the NH-+0 substitu- 
tion at the P’2 position enhanced the binding to PPE by 
only a factor of 2. 
The significant decrease in binding and stability for the 
control analog (8-70)T44L eglin c deserves some com- 
ments. In wild-type eglin c, the sidechain of Thr44 is H- 
bonded to both Arg53 and Asp46 (Figure 6). Replacement 
of the P2 threonine by leucine will undoubtedly weaken 
the internal rigidity of the reactive-site peptide bond. It is 
known that a rigid reactive-site peptide bond will effec- 
tively elevate the activation energy barrier to the transi- 
tion state, deterring a productive nucleophilic attack on 
the peptide bond by the enzyme. Heinz et al. [2X] 
reported that although an Arg53+Lys mutation weakened 
the binding to SCAR, replacement of Thr44 by proline in 
eglin c converted the inhibitor to a substrate. Our data 
have shown that the P2 Thr-+Leu substitution not only 
destabilized the protein (by more than lO”C), but also sig- 
nificantly weakened the binding to CHYM and SCAR by 
four orders of magnitude. It is worth pointing out that 
PPE is much more tolerant towards a Thr44+Leu muta- 
tion at the P2 position, which can probably be attributed 
to a substantially different subsite-binding pocket in the 
enzyme [29]. 
The P3 position 
The amide NH group at the P3 position is H-bonded to 
Gly2160 in CHYM and Glyl270 in SCAR. The P3 
NH-0 substitution weakened the binding to CHYM by 
tenfold, but did not affect the binding to SCAR. In con- 
trast, it weakened the binding to PPE by 150-fold. These 
discriminating effects seen at the P3 position are difficult 
to understand and will be further investigated. 
The Pl’ position 
We were unable to purify the two Pl’ analogs (S-70)D46L 
and (8-70)D46[O]L using methyl-chymotrypsin affinity 
chromatography. The Pl’ aspartate in eglin c is a struc- 
turally important residue participating in extensive elec- 
trostatic/H-bonding interactions involving Arg48, Arg51 
and Gly70 (Figure 6). These interactions are believed to 
be critical in maintaining the rigidity of the enzyme- 
binding loop of the inhibitor. Heinz et al: [28] demon- 
strated that mutation of Pl’ Asp or Arg.51 resulted in 
conversion of the inhibitor into a substrate with trypsin 
and SCAR. A similar result has also been observed in our 
laboratory with respect to Gly70. Using total chemical syn- 
thesis, we have shown that replacement of the carboxylate 
group (-COO-) of Gly70 by a neutral amide terminus 
(-CONH,) destabilized the inhibitor by as much as 20°C 
at pH 5.4, and caused a weak binding and much acceler- 
ated hydrolysis at the reactive site of the inhibitor by both 
SCAR and CHYM (W-Y. Lu, hl. Starovasnik, J. Dwyer, 
A.K., S.B.H.K. and W.L., unpublished observations). 
Incorporation of either leucine or leucic acid at the Pl’ 
position apparently compromised the electrostatic interac- 
tions helping to rigidify the binding loop of the inhibitor, 
therefore undermining the binding of mutant eglin c to 
the affinity column. We expect that the direct incorpora- 
tion of Asp-derived a-hydroxyl carboxylic acid at Pl’ of 
eglin c will help eliminate this problem. 
The P2’ position 
The amide NH group of the P2’ residue is H-bonded to 
Phe410 in CHYM and Asn2180 in SCAR. Removal of 
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this H-bond caused a decrease in binding to CHYM, 
SCAR and PPE by 30-fold, ZO-fold and tenfold, respec- 
tively. Our results are in good agreement with that 
reported by Groeger et al. [30] in which the P2’ NH-+0 
substitution in R17G-BPTI decreased the binding of 
BPTI to trypsin by &fold (1.9 kcal/mol). 
Significance 
Recent advances in the total chemical synthesis of pro- 
teins and development of chemical ligation techniques 
have presented us with an opportunity to explore protein 
structure and function relationships in a highly system- 
atic fashion. In the work reported here, high-resolution 
X-ray crystallography showed that chemical synthesis of 
eglin c, a protein inhibitor of many serine proteases, by 
native chemical ligation did not alter the protein struc- 
ture. Chemical protein engineering using noncoded 
amino acids and unnatural backbone structures will 
broaden our understanding of the molecular basis of how 
proteins function. This paper represents a major 
example of the growing efforts in using chemistry to 
investigate the energetic significance of H-bonding in 
protein recognition, in this case using backbone-back- 
bone interactions. 
H-bonding contributions are believed to be context- 
dependent. Some of the apparent free-energy changes, 
MG, associated with the amide-ester replacements in 
the binding loop of eglin c are, however, clearly beyond 
the interpretation of loss of backbone H-bonds. Our data 
suggest that interplay of rigidity and adaptability of the 
binding loop in eglin c plays an important role in dictating 
its binding action. Of particular interest is the NH-+0 
substitution at the P2 position that leads to an unex- 
pected enhancement in both binding and stability. This 
observation clearly deserves further analysis using 
nuclear magnetic resonance and X-ray crystallography. 
Materials and methods 
Boc-L-amino acids and 2-(1 H-benzotriazol-1 -yl)-1 ,1,3,3tetramethyluro- 
niumhexafluorophosphate (HBTU) were purchased from Novabiochem; 
Boc-Gly-OCH,-Pam-resin and /V,N-diisopropylethylamine (DIEA) were 
obtained from Applied Biosystems. Aminomethyl-resin was prepared 
by Michael Carrasco according to published procedures [31 I. L-Leucic 
acid (S-2-hydroxyisocaproic acid), benzyl bromide, benzyl mercaptan 
and thiophenol were purchased from Aldrich Chemical Co CHYM and 
PPE were purchased from Worthington Biochemical Co; SCAR was 
obtained from Sigma Chemical Co Chromogenic substrates used in 
binding assays were purchased from Bachem Bioscience Inc. All other 
commonly used chemicals were obtained in analytical grade or better, 
as indicated in previous publications. 
Methyl-chymotrypsin was prepared according to Ryan and Feeney 
[32], and was coupled to CNBr-activated Sepharose 4B (Pharmacia) 
according to the coupling procedures provided by the manufacturer. 
Analytical reversed phase (RP)-HPLC was performed on an Hewlett 
Packard Series 1050 equipped with a Vydac C-l 8 column (5 urn, 
4.6 x 150 mm); Preparative RP-HPLC was carried out on a Waters 
Delta Prep 4000 system using a Vydac C-l 8 column (15-20 urn, 50 x 
250 mm); Solvent A for HPLC was water containing 0.1% TFA; 
Solvent B was 90% ACN containing 0.090/, TFA. Mass spectrometry 
analysis was carried out on a PE Sciex API-III quadrupole electrospray 
ionization (ESI) mass spectrometer. Thermal denaturation was per- 
formed on a differential scanning calorimeter (Nano-DSC from 
Calorimetry Sciences) at pH 5.4. 
The inhibitor-enzyme association equilibrium constants (Ka) were mea- 
sured on a Hewlett Packard HP8450A spectrophotometer by a modi- 
fied version of the Green and Work method [33,34]. The experiment 
was carried out at room temperature in 0.1 M Bis-Tris buffer containing 
0.02 M CaCI,, 0.005% Triton X-100 and 1 mM P-mercaptoethanol, 
pH 7.0. For most enzymes, the dynamic range of K, values is from 
1 O3 to 1 O’* with an accuracy of f 20%. 
Synthesis of ‘wild-type’ (8-7O)S4 1 C eglin c 
The synthetic strategy for (8-7O)S41 C eglin c is outlined in Figure 1. In 
brief, syntheses of two peptide segments, (8-40)aCOSH and 
(41-7O)S41 C, were carried out manually in a stepwise fashion on Boc- 
Gly-(thioester-linker)-aminomethyl-resin [35] and Boc-Gly-OCH,-Pam- 
resin, respectively, using the published in situ neutralization/HBTU 
activation protocol for Boc chemistry [36]. After deprotection and cleav- 
age in HF, crude thioacid peptide (8-40)oCOSH was allowed to react 
with benzyl bromide to yield thioester peptide (8-40)aCOSBzl , which 
was then purified by preparative C-18 RP-HPLC. The crude carboxy- 
terminal peptide (41-7O)S41 C was also purified by preparative C-l 8 
RP-HPLC prior to ligation. 
The ligation of (8-40)aCOSBzl and (41.7O)S41C was carried out at 
pH 7.5 in the presence of 6 M GuHCI, 1% benzyl mercaptan and 3% 
thiophenol, as described previously [37,38] (Figure 7). The reaction 
was allowed to proceed to completion in 24 h, and the resultant ligation 
product was purified on preparative C-l 8 RP-HPLC. The purified, syn- 
thetic (8-7O)S41C eglin c was characterized by ESI-MS (observed 
mass 7342.5 f. 1 .l Da, calculated average isotope mass 7342.4 Da). 
Protein folding was carried out by dissolving (8-7O)S41C eglin c at 
1.2 mg/ml in 6 M GuHCI, 6 mM EDTA, which was then diluted with 
50 mM MES, 1 mM DTT, pH 6.0 buffer and water (final protein concen- 
tration -0.2 mglml). After 3 h, the folding solution was loaded onto a 
methyl-chymotrypsin-Sepharose column. The active, folded protein was 
eluted by lowering the pH to 2.0. The overall yield was 70 mg of pure, 
active protein out of a typical 0.2 mmol scale synthesis, i.e. 5%. 
Syntheses of analogs of (8-7O)S4 IC eglin c 
Parallel syntheses of five backbone-engineered ester analogs and three 
reference proteins (excluding wild type) were performed essentially as 
for the ‘wild-type’ molecule. The target sequences are illustrated in 
Figure 8. Principles for the incorporation of an ester bond into peptides 
have been described previously [15]. After loading of leucic acid, triple 
couplings (2 h each) were used for the subsequent esterification reac- 
tion. Small amounts of unreacted peptides were acetylated by sus- 
pending resins in 5 ml of DMFlDCM (1:l) containing 240 ul acetic 
anhydride, 120 ul N-ethylmorpholine, and 50 mg 4-(dimethylamino) 
pyridine for 60 min. After deprotection and cleavage in HF, crude ester- 
containing and Leu-substituted peptides (41-7O)S41 C were directly 
ligated with (8-40)aCOSBzl without further purification. 
Conditions under which ligation, purification and folding were con- 
ducted were identical to those used in the synthesis of ‘wild-type’ 
(8-7O)S41 C eglin c. Prior to refolding, all the analogs were analyzed 
by ESI-MS and observed molecular weights were within experimental 
error of calculated average isotope masses without exception (data 
not shown). 
Crystallization and data collection 
The SBPN-eglin complex was crystallized using the procedure of 
Heinz et al. [19]. These conditions produced small prisms of trigonal 
cross-section having the space group P3,21. The cell constants are 
a = b = 86 A, c = 106 A giving a Matthews constant of V, = 3.0 and a 
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(a) Ligation reaction. (b) Ligated eglin c after purification. The ligation 
reaction was monitored by analytical C-l 8 RP-HPLC (25-50% B over 
24 min) and ESI-MS (inset in (b); for details see the Materials and 
methods section). 
solvent content of about 60%. These crystals had slightly different cell 
constants, however, than those previously reported by Heinz et al.: 
a= b=85A, c=90 A [19]. Interestingly, the space groups are also 
different P3,21 versus P3,21; the rather simple packing adjustment 
along the c axis therefore alters the internal symmetry of the crystal. 
Data were collected from one crystal that was exposed to a mother liquor 
containing 15% glycerol. The treated crystal was then scooped into a 
small nylon loop and flash frozen by manually plunging the loop into liquid 
nitrogen. The crystal was mounted on a MAR image plate detector at a 
crystal to detector distance of 25 cm. The X-ray source was a Rigaku 
RU2000 set at 120 mA and 45 kV. The crystal was maintained at 100 K 
during data collection using an Oxford Cryo-stream system. In all, 
101 ,149 observations were collected between 20.0 A to 1.98 A resolu- 
tion. The data were reduced by MARXDS and scaled using MARSCALE 
[39] resulting in an Rmerge of 7% (29% between 2.1 to 1.98 A). These 
data reduced to 28,638 unique reflections having 96% completeness 
Ester analogs 
P4 P3’ 
. Pro-[O]Leu-Thr-Leu-Asp-Leu-Arg... 
. . . Pro-Val-[OlLeu-Leu-Asp-Leu-Arg... 
. . . Pro-Val-Thr-[OILeu-Asp-Leu-Arg... 
. . Pro-Val-Thr-Leu-[O]Leu-Leu-Arg... 
. . . Pro-Val-Thr-Leu-Asp-[O]Leu-Arg... 
Control analogs 
P4 P3’ 
. . Pro-Leu-Thr-Leu-Asp-Leu-Arg... 
. . Pro-Val-Leu-Leu-Asp-Leu-Arg... 
. . Pro-Val-Thr-Leu-Asp-Leu-Arg...* 
. . . Pro-Val-Thr-Leu-Leu-Leu-Arg... 
. Pro-Val-Thr-Leu-Asp-Leu-Arg...* 
Chemistry & Biology 
Amino acid sequences of the binding loop of eglin c where leucic acid 
and leucine were inserted. It is worth noting that our ‘wild-type’ eglin c 
(labeled with *), although functionally identical to the naturally occurring 
counterpart, differs on two counts. First, our version is amino-terminally 
truncated. Second, it contains a Ser-+Cys mutation at position 41. 
over the total range. Approximately 5% of the data were removed to be 
used in calculation of the free R value (R) during refinement. 
Structure solution and refinement 
The structure was solved using the rotation and translation search rou- 
tines in Amore [40]. The model used was that from the Heinz et a/. 
analysis (PDB 1SBN) [41]. The procedure gave a distinctive rotation 
solution with a peak height of four times the next unrelated solution. The 
rotation solution was then subjected to a translation search in both pos- 
sible space groups, P3,21 and P3,21, which cannot be differentiated 
based on the symmetry of the diffracted intensities alone. It is only 
through this translation search that the space group ambiguity can be 
sorted out. In space group P3,21 the best solution had an R-value of 
0.53; the best solution for space group P3,21 was R = 0.41. This com- 
parison clearly indicated the latter space group to be the correct one. 
The structure was refined using XPLOR [42]. The initial model included 
residues l-275 for SBPN and 8-70 for eglin. All data from 20 A to 
2.0 A were used. The data were corrected for anisotropic scattering 
(correction a = b = -1.9 Az, c = 3.7 A*), The final model also included 
307 water molecules and one calcium ion. This model gave an R value 
of 0.169 and an R, of 0.213. A full description of the experimental 
details and structure analysis will be reported elsewhere (A.K. and 
M.R., unpublished observations). 
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